Bacterial infections, sepsis, and multiorgan failure in cirrhosis

被引:404
作者
Tandon, Puneeta [1 ]
Garcia-Tsao, Guadalupe [2 ]
机构
[1] Univ Alberta, Div Gastroenterol, Edmonton, AB, Canada
[2] Yale Univ, Sch Med, Sect Digest Dis, Dept Internal Med, New Haven, CT 06520 USA
关键词
bacterial infection; spontaneous bacterial peritonitis; cirrhosis; bacterial translocation; sepsis; SIRS; multiorgan failure;
D O I
10.1055/s-2008-1040319
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Bacterial infections are an important complication of cirrhosis, particularly in hospitalized patients. In this article we review the prevalence, risk factors, and pathogenesis of bacterial infections in cirrhosis, focusing on the mechanisms of bacterial translocation such as impaired immunity and bacterial overgrowth, as well as maneuvers that may inhibit bacterial translocation and could be used not only to prevent infections but also to ameliorate the hyperdynamic circulatory state of cirrhosis. We also review the clinical features and management of the most common infection in cirrhosis, spontaneous bacterial peritonitis (SBP), specifically the evidence behind the therapy of acute SBP, the role of albumin, and the role of antibiotics in the prophylaxis of high-risk patients. It has been recognized that SBP and other bacterial infections lead to the systemic inflammatory response syndrome, sepsis, and multiorgan failure. We review the pathogenesis and management of these complications, the role of adrenal insufficiency, and the utility of intensive care prognostic models.
引用
收藏
页码:26 / 42
页数:17
相关论文
共 191 条
[1]   Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis [J].
Abraldes, JG ;
Tarantino, I ;
Turnes, J ;
Garcia-Pagan, JC ;
Rodés, J ;
Bosch, J .
HEPATOLOGY, 2003, 37 (04) :902-908
[2]   Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU [J].
Aggarwal, A ;
Ong, JP ;
Younossi, ZM ;
Nelson, DR ;
Hoffman-Hogg, L ;
Arroliga, AC .
CHEST, 2001, 119 (05) :1489-1497
[3]  
AKALIN HE, 1985, Q J MED, V56, P431
[4]   Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients [J].
Alberti, C ;
Brun-Buisson, C ;
Goodman, SV ;
Guidici, D ;
Granton, J ;
Moreno, R ;
Smithies, M ;
Thomas, O ;
Artigas, A ;
Le Gall, JR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (01) :77-84
[5]   Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites [J].
Albillos, A ;
de-La-Hera, A ;
Alvarez-Mon, M .
LANCET, 2004, 363 (9421) :1608-1610
[6]   Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis:: amelioration with norfloxacin [J].
Albillos, A ;
de la Hera, A ;
Reyes, E ;
Monserrat, J ;
Muñoz, L ;
Nieto, M ;
Prieto, A ;
Sanz, E ;
Alvarez-Mon, M .
JOURNAL OF HEPATOLOGY, 2004, 40 (04) :624-631
[7]   Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement [J].
Albillos, A ;
de la Hera, A ;
González, M ;
Moya, JL ;
Calleja, JL ;
Monserrat, J ;
Ruiz-del-Arbol, L ;
Alvarez-Mon, M .
HEPATOLOGY, 2003, 37 (01) :208-217
[8]  
ALTURA BM, 1972, P SOC EXP BIOL MED, V139, P935
[9]   Coagulation disorders in liver disease [J].
Amitrano, L ;
Guardascione, MA ;
Brancaccio, V ;
Balzano, A .
SEMINARS IN LIVER DISEASE, 2002, 22 (01) :83-96
[10]   Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide [J].
Angeli, P ;
Volpin, R ;
Gerunda, G ;
Craighero, R ;
Rone, P ;
Merenda, R ;
Amodio, P ;
Sticca, A ;
Caregaro, L ;
Maffei-Faccioli, A ;
Gatta, A .
HEPATOLOGY, 1999, 29 (06) :1690-1697